Bioharvest Sciences Stock Performance
| CNVCF Stock | USD 6.15 0.03 0.49% |
On a scale of 0 to 100, Bioharvest Sciences holds a performance score of 5. The firm shows a Beta (market volatility) of -0.25, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Bioharvest Sciences are expected to decrease at a much lower rate. During the bear market, Bioharvest Sciences is likely to outperform the market. Please check Bioharvest Sciences' total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to make a quick decision on whether Bioharvest Sciences' price patterns will revert.
Risk-Adjusted Performance
5 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Bioharvest Sciences are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady fundamental indicators, Bioharvest Sciences reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
Five Day Return 1.45 | Year To Date Return 12.5 | Ten Year Return 5.35 | All Time Return 5.35 |
| Begin Period Cash Flow | 1.8 M | |
| Total Cashflows From Investing Activities | -1.6 M |
Bioharvest |
Bioharvest Sciences Relative Risk vs. Return Landscape
If you would invest 550.00 in Bioharvest Sciences on September 2, 2024 and sell it today you would earn a total of 65.00 from holding Bioharvest Sciences or generate 11.82% return on investment over 90 days. Bioharvest Sciences is currently producing 0.2382% returns and takes up 3.6178% volatility of returns over 90 trading days. Put another way, 32% of traded otc stocks are less volatile than Bioharvest, and 96% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Bioharvest Sciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bioharvest Sciences' investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Bioharvest Sciences, and traders can use it to determine the average amount a Bioharvest Sciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0658
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CNVCF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.62 actual daily | 32 68% of assets are more volatile |
Expected Return
| 0.24 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Bioharvest Sciences is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bioharvest Sciences by adding it to a well-diversified portfolio.
Bioharvest Sciences Fundamentals Growth
Bioharvest OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Bioharvest Sciences, and Bioharvest Sciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bioharvest OTC Stock performance.
| Return On Equity | -63.64 | |||
| Return On Asset | -0.53 | |||
| Profit Margin | (2.69) % | |||
| Operating Margin | (2.45) % | |||
| Current Valuation | 106.97 M | |||
| Shares Outstanding | 460.72 M | |||
| Price To Book | 91.96 X | |||
| Price To Sales | 28.13 X | |||
| Revenue | 2.1 M | |||
| EBITDA | (8.63 M) | |||
| Cash And Equivalents | 1.21 M | |||
| Total Debt | 3.97 M | |||
| Debt To Equity | 1.62 % | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (6.79 M) | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 10.21 M | |||
About Bioharvest Sciences Performance
By analyzing Bioharvest Sciences' fundamental ratios, stakeholders can gain valuable insights into Bioharvest Sciences' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bioharvest Sciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bioharvest Sciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product and medical cannabis. Canna-V-Cell Sciences is traded on OTC Exchange in the United States.Things to note about Bioharvest Sciences performance evaluation
Checking the ongoing alerts about Bioharvest Sciences for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Bioharvest Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bioharvest Sciences had very high historical volatility over the last 90 days | |
| Bioharvest Sciences has accumulated 3.97 M in total debt with debt to equity ratio (D/E) of 1.62, which is about average as compared to similar companies. Bioharvest Sciences has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Bioharvest Sciences until it has trouble settling it off, either with new capital or with free cash flow. So, Bioharvest Sciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bioharvest Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bioharvest to invest in growth at high rates of return. When we think about Bioharvest Sciences' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 2.1 M. Net Loss for the year was (9.83 M) with profit before overhead, payroll, taxes, and interest of 670 K. | |
| Bioharvest Sciences has accumulated about 1.21 M in cash with (6.79 M) of positive cash flow from operations. | |
| Roughly 35.0% of Bioharvest Sciences shares are held by company insiders |
- Analyzing Bioharvest Sciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bioharvest Sciences' stock is overvalued or undervalued compared to its peers.
- Examining Bioharvest Sciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bioharvest Sciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bioharvest Sciences' management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Bioharvest Sciences' otc stock. These opinions can provide insight into Bioharvest Sciences' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bioharvest OTC Stock analysis
When running Bioharvest Sciences' price analysis, check to measure Bioharvest Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioharvest Sciences is operating at the current time. Most of Bioharvest Sciences' value examination focuses on studying past and present price action to predict the probability of Bioharvest Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioharvest Sciences' price. Additionally, you may evaluate how the addition of Bioharvest Sciences to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |